136 related articles for article (PubMed ID: 38176331)
21. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991.
Cavalieri R; Macchini V; Mostaccioli S; Sonego G; Ferranti G; Corona R; Fucci M; Marzolini F; Rosmini F; Pasquini P
Ann Ist Super Sanita; 1993; 29(3):469-72. PubMed ID: 8172468
[TBL] [Abstract][Full Text] [Related]
22. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
23. Disease mapping of early- and late-stage cancer to monitor inequalities in early detection: a study of cutaneous malignant melanoma.
Strömberg U; Parkes BL; Holmén A; Peterson S; Holmberg E; Baigi A; Piel FB
Eur J Epidemiol; 2020 Jun; 35(6):537-547. PubMed ID: 32350689
[TBL] [Abstract][Full Text] [Related]
24. Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.
Islami F; Ward EM; Sung H; Cronin KA; Tangka FKL; Sherman RL; Zhao J; Anderson RN; Henley SJ; Yabroff KR; Jemal A; Benard VB
J Natl Cancer Inst; 2021 Nov; 113(12):1648-1669. PubMed ID: 34240195
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous malignant melanoma incidence rates in Norway.
Moan J; Baturaite Z; Grigalavicius M; Juzeniene A
Scand J Public Health; 2013 Jun; 41(4):336-9. PubMed ID: 23439631
[TBL] [Abstract][Full Text] [Related]
26. The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031.
Whiteman DC; Green AC; Olsen CM
J Invest Dermatol; 2016 Jun; 136(6):1161-1171. PubMed ID: 26902923
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
Lasithiotakis K; Leiter U; Krüger-Krasagakis S; Tosca A; Garbe C
Br J Dermatol; 2006 Jun; 154(6):1123-7. PubMed ID: 16704644
[TBL] [Abstract][Full Text] [Related]
28. Smallpox and BCG vaccination in childhood and cutaneous malignant melanoma in Danish adults followed from 18 to 49 years.
Rieckmann A; Meyle KD; Rod NH; Baker JL; Benn CS; Aaby P; Sørup S
Vaccine; 2019 Oct; 37(44):6730-6736. PubMed ID: 31537447
[TBL] [Abstract][Full Text] [Related]
29. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
[TBL] [Abstract][Full Text] [Related]
30. Malignant melanoma: incidence issues and their effect on diagnosis and treatment in the 1990s.
Rigel DS
Mayo Clin Proc; 1997 Apr; 72(4):367-71. PubMed ID: 9121186
[TBL] [Abstract][Full Text] [Related]
31. Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma.
Anderson WF; Pfeiffer RM; Tucker MA; Rosenberg PS
Cancer; 2009 Sep; 115(18):4176-85. PubMed ID: 19536874
[TBL] [Abstract][Full Text] [Related]
32. Incidence of cutaneous malignant melanoma in Israel, 1960-1989.
Iscovich J; Andreev H; Steinitz R
Public Health Rev; 1995; 23(1):1-23. PubMed ID: 7761605
[TBL] [Abstract][Full Text] [Related]
33. Melanoma Incidence Among Non-Hispanic Whites in All 50 US States From 2001 Through 2015.
Thrift AP; Gudenkauf FJ
J Natl Cancer Inst; 2020 May; 112(5):533-539. PubMed ID: 31346623
[TBL] [Abstract][Full Text] [Related]
34. Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective.
Buja A; Rugge M; De Luca G; Zorzi M; Cozzolino C; Vecchiato A; Del Fiore P; Tropea S; Bortolami A; Benini P; Rossi CR; Mocellin S
Melanoma Res; 2022 Oct; 32(5):353-359. PubMed ID: 35855661
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of cutaneous malignant melanoma in Reunion Island.
Chirpaz E; Warocquier J; Filisetti C; Beylot-Barry M; Bertolotti A; Sultan N
Ann Dermatol Venereol; 2022 Mar; 149(1):39-44. PubMed ID: 35131081
[TBL] [Abstract][Full Text] [Related]
36. The impact of autoimmune diseases on the incidence and prognosis of cutaneous malignant melanoma.
Kaae J; Wohlfahrt J; Boyd HA; Wulf HC; Biggar RJ; Melbye M
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1840-4. PubMed ID: 17855703
[TBL] [Abstract][Full Text] [Related]
37. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland.
Levi F; Te VC; Randimbison L; La Vecchia C
Melanoma Res; 2005 Feb; 15(1):73-5. PubMed ID: 15714124
[TBL] [Abstract][Full Text] [Related]
38. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Fraser MC; Clark WH; Tucker MA
J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
[TBL] [Abstract][Full Text] [Related]
39. Influence of having a home garden on personal UVR exposure behavior and risk of cutaneous malignant melanoma in Denmark.
Idorn LW; Thieden E; Philipsen PA; Wulf HC
Int J Cancer; 2013 Mar; 132(6):1383-8. PubMed ID: 22821769
[TBL] [Abstract][Full Text] [Related]
40. Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US.
Adamson AS; Suarez EA; Welch HG
JAMA Dermatol; 2022 Apr; 158(4):426-431. PubMed ID: 35293957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
